Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Colorectal Neoplasms 2Patient Preference 1Diabetes Mellitus 1Coronary Disease 1Breast Neoplasms 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Has results × Risk Assessment × Clear all
NCT01468675 2017-04-28

Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care

Brigham and Women's Hospital

Phase NA Completed
6,075 enrolled 5 charts
BreastGastrointestinal

Breast Neoplasms, Coronary Disease, Diabetes Mellitus, Colorectal Neoplasms

NCT01596582 2017-03-21

Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening

Boston Medical Center

Phase NA Completed
352 enrolled 19 charts
Gastrointestinal

Colorectal Neoplasms, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡